AR091239A1 - VIRUS INFECCIOSO DE SCHMALLENBERG DE cADN CLONADOS Y SUS USOS - Google Patents

VIRUS INFECCIOSO DE SCHMALLENBERG DE cADN CLONADOS Y SUS USOS

Info

Publication number
AR091239A1
AR091239A1 ARP130101935A AR091239A1 AR 091239 A1 AR091239 A1 AR 091239A1 AR P130101935 A ARP130101935 A AR P130101935A AR 091239 A1 AR091239 A1 AR 091239A1
Authority
AR
Argentina
Prior art keywords
schmallenberg
sbv
clonates
cdna
infectious virus
Prior art date
Application number
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of AR091239A1 publication Critical patent/AR091239A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12041—Use of virus, viral particle or viral elements as a vector
    • C12N2760/12043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Una secuencia de ácido nucleico que comprende el genoma completo de un virus infeccioso de Schmallenberg (SBV) de utilidad para estudiar viremia y enfermedades causadas por SBV en rumiantes y en el desarrollo de vacunas, agentes terapéuticos y diagnósticos para la prevención, tratamiento y diagnosis de viremia y enfermedades causadas por SBV. Constructo, célula, virus, composición farmacéutica, método de producción.
ARP130101935 2012-06-01 2013-05-31 VIRUS INFECCIOSO DE SCHMALLENBERG DE cADN CLONADOS Y SUS USOS AR091239A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12170630 2012-06-01

Publications (1)

Publication Number Publication Date
AR091239A1 true AR091239A1 (es) 2015-01-21

Family

ID=48537980

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130101935 AR091239A1 (es) 2012-06-01 2013-05-31 VIRUS INFECCIOSO DE SCHMALLENBERG DE cADN CLONADOS Y SUS USOS

Country Status (5)

Country Link
US (1) US9241960B2 (es)
EP (1) EP2855512B1 (es)
AR (1) AR091239A1 (es)
UY (1) UY34841A (es)
WO (1) WO2013178711A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2855513T3 (pl) 2012-06-01 2017-05-31 Boehringer Ingelheim Vetmedica Gmbh Szczepionka przeciwko wirusowi Schmallenberg (SBV), sposoby wytwarzania i jej zastosowanie
WO2013178711A1 (en) 2012-06-01 2013-12-05 Boehringer Ingelheim Vetmedica Gmbh Genomic sequences of schmallenberg virus and uses thereof
ES2893282T3 (es) * 2019-05-10 2022-02-08 Pasteur Institut Un nuevo orthobunyavirus en la encefalitis humana y su diagnóstico y aplicaciones terapéuticas
CN115057925B (zh) * 2022-06-22 2024-03-26 中国检验检疫科学研究院 一种抗赤羽病病毒单克隆抗体及其应用
CN118308312A (zh) * 2024-06-07 2024-07-09 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 一种表达报告基因的重组阿卡斑病毒及构建方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008112707A1 (en) 2007-03-13 2008-09-18 Peros Systems Technologies, Inc. Immunoactive compositions for improved oral delivery of vaccines and therapeutic agents
PL2855513T3 (pl) 2012-06-01 2017-05-31 Boehringer Ingelheim Vetmedica Gmbh Szczepionka przeciwko wirusowi Schmallenberg (SBV), sposoby wytwarzania i jej zastosowanie
WO2013178711A1 (en) 2012-06-01 2013-12-05 Boehringer Ingelheim Vetmedica Gmbh Genomic sequences of schmallenberg virus and uses thereof

Also Published As

Publication number Publication date
US20130323210A1 (en) 2013-12-05
US9241960B2 (en) 2016-01-26
UY34841A (es) 2013-12-31
EP2855512B1 (en) 2018-02-28
EP2855512A1 (en) 2015-04-08
WO2013178711A1 (en) 2013-12-05

Similar Documents

Publication Publication Date Title
IL285107A (en) Diagnostic, prognostic and therapeutic uses of long non-coding RNA molecules for heart diseases and rehabilitation medicine
BR112018008102A2 (pt) vacina de vírus sincicial respiratório
BR112012032008A2 (pt) anticorpos s100a4 e usos terapêuticos do mesmo
CO7240369A2 (es) Ácido 5-aminotetrahidroquinolin-2-carboxílicos novedosos y su uso
BR112015014462A2 (pt) vetorização farmacêutica de uma via de sinalização de dinucleotídeos cíclicos de mamíferos
CY1118813T1 (el) Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων
UY33370A (es) Composiciones farmacéuticas comprendiendo un fármaco inhibidor de la DPP4 y de la pioglitazona, procedimientos de preparación y utilización
DOP2014000170A (es) Compuestos de imidazopirrolidinona
AR091316A1 (es) Moleculas de union humanas que se pueden unir y neutralizar a los virus de la influenza b y sus usos
CL2013001428A1 (es) Compuesto que inhibe la actividad del virus de la hepatitis c (hcv); composición farmacéutica que comprende el compuesto; método de tratamiento de hepatitis c.
CL2014001345A1 (es) Metodos de tratamiento usando un anticuerpo contra interferon gamma; usos composicion farmaceutica que contiene un anticuerpo contra interferon gamma.
AR090465A1 (es) Formas solidas de un profarmaco de nucleotidos de tiofosforamidato
ECSP12011834A (es) Composición farmacéutica, forma de dosificación farmacéutica, procedimiento para su preparación, métodos para su tratamiento y sus usos.
BR112017005111A2 (pt) compostos, composição farmacêutica, usos de um composto ou de um sal farmaceuticamente aceitável do mesmo para o tratamento de um hospedeiro infectado com um papilomavírus humano, usos de um composto, método para a fabricação de um medicamento destinado ao uso terapêutico para o tratamento de uma infecção por papilomavírus
MX350282B (es) Molecula de union que tiene actividad neutralizadora del virus de la influenza a, producida a partir de celulas b humanas.
AR091239A1 (es) VIRUS INFECCIOSO DE SCHMALLENBERG DE cADN CLONADOS Y SUS USOS
EA201600476A1 (ru) Вариант вируса ppcc, клон кднк вируса ppcc европейского типа и их применение
UY34420A (es) ?métodos de tratamiento del virus de la hepatitis c con que de gs-7977 y ribavirina, composiciones y usos"
CL2016000300A1 (es) Métodos terapéuticos
CO7131387A2 (es) Composiciones y métodos de polipéptidos-complejo de quelato de oligonucleótido
CL2015003563A1 (es) Marcador para trastornos de la esfingomielinasa ácida y sus usos.
BR112013019924A8 (pt) Composições para cuidado oral
BR112014028632A8 (pt) Composto, composição farmacêutica, e, método para preparar um composto
AR091240A1 (es) Vacuna de virus de schmallenberg (sbv), metodos de produccion y sus usos
EA201391742A1 (ru) Фармацевтическая композиция, включающая фексофенадин

Legal Events

Date Code Title Description
FB Suspension of granting procedure